Idiopathic in Medical Technology
Navigation Links
Idiopathic in Medical Technology
... studies evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented today in ... Shionogi in that country.
About IPF
idiopathic pulmonary fibrosis (IPF) is a disabling and ... InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus ...
... new combination therapy for previously untreated idiopathic thrombocytopenic purpura (ITP), an ... in adult patients with previously untreated idiopathic thrombocytopenic purpura (ITP). The results of ... the Long-Term Treatment of Patients With Chronic idiopathic Thrombocytopenic Purpura (ITP): Results of a ...
... (RA) in adults, and polyarticular juvenile idiopathic arthritis (JIA) in children.(1) ... physical function. Polyarticular juvenile idiopathic arthritis Treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents aged 4 to ...
... at a 24 mcg dose for the treatment of Chronic idiopathic Constipation in adults. These data were among ... About AMITIZA(R) (lubiprostone) for Chronic idiopathic Constipation and IBS-C Indication AMITIZA(R) ... AMITIZA(R) (lubiprostone) in the U.S. for Chronic idiopathic Constipation in adults and Irritable ...
... to severely active polyarticular juvenile idiopathic arthritis (JIA). ORENCIA may be used as ... such as MTX or TNF antagonists. "Juvenile idiopathic arthritis is the most prevalent form of ... while on open-label treatment. About Juvenile idiopathic Arthritis (JIA) JIA -- also commonly known as ...
... allergies, as well as the treatment of chronic idiopathic urticaria. XYZAL(R) tablets received FDA approval ... runny nose, and itchy eyes. Studies in chronic idiopathic urticaria patients showed levocetirizine ... of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age ...
... Studies in Patients with Moderate-to-Severe idiopathic RLS SP 790 * In a multi-center, double-blind, ... efficacy in patients with moderate-to-severe idiopathic RLS who were treated for 24 months * A total ... States for the treatment of early-stage idiopathic Parkinson's disease and in Europe for the ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. ACTEMRA (known as RoACTEMRA in ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. ACTEMRA (known as RoACTEMRA in ...
... are indicated in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease (PD) and for moderate-to-severe primary restless legs ... and Drug Administration for the treatment of the signs and symptoms of idiopathic Parkinson's disease (PD). Boehringer Ingelheim Pharmaceuticals, Inc. ...
... thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, ... pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. The serious adverse reactions ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. The serious adverse reactions ...
... research with imatinib mesylate in another non-oncology disease called idiopathic pulmonary fibrosis (IPF), a condition in which the lungs become ... data analysis 6. National Library of Medicine Medical Encyclopedia. idiopathic pulmonary fibrosis. Gleevec(R) (imatinib mesylate) tablets prescribing ...
... tablets) in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease. Requip XL is the first and only oral once-daily ... are indicated in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease and are administered once daily. Prescription Requip ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. The serious adverse events ...
... ACTEMRA was approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis in Japan. The serious adverse events reported in ACTEMRA ...
... tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. Keppra(R) injection is indicated as adjunctive ... neck pain, and pharyngitis. In patients 6 years of age and older with idiopathic generalized epilepsy, the most common adverse event associated with ...
... United States for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease, and in Europe for the treatment of patients with ... is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease. Some patients treated with Neupro(R) reported falling ...
... oral gel capsules, twice daily) is indicated for the treatment of Chronic idiopathic Constipation in adults. AMITIZA should not be used in patients with a ... should consult their health professional. In clinical trials for Chronic idiopathic Constipation (24 mcg, oral gel capsules, twice daily), the most common ...
... (abatacept) for the treatment of pediatric patients with juvenile idiopathic arthritis (JIA) who have had an inadequate response to one or more ... signal required for full T-cell activation. About Juvenile idiopathic Arthritis JIA -- also commonly known as juvenile rheumatoid arthritis ...
... support the further development of TELINTRA. Phase 2 studies are ongoing in MDS (enrollment completion expected by year end), and Severe Chronic idiopathic Neutropenia. Reprints of both publications are available from Telik. Background on MDS and TELINTRA MDS is a heterogeneous group of ...
... patients they treat." About the Study The randomized, double-blind, 16-week, placebo-controlled Phase 3 study monitored 405 patients with idiopathic PAH or PAH associated with anorexigen use, connective tissue disease, human immunodeficiency virus (HIV) infection, or congenital ...
... buffered saline (IA-SA) for level of pain following a 50-Foot Walk Test, measured by 100 mm visual analog scale (VAS). The 586 patients with chronic idiopathic knee OA were randomized to treatment with either product in a 1:1 ratio. Each patient received one weekly injection for 3 weeks with 9 follow-up ...
... This team identified the key role played by this mutation of the JAK2 gene in the development of MPN such as Vaquez disease (Polycythemia Vera), idiopathic Myelofibrose or Essential Thrombocythemia. Following this agreement, the company developed and marketed a complete portfolio of tests for the ...
... hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, lupus, rheumatoid arthritis and interstitial nephritis), pulmonary ...
... the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which a Phase 3 program in ...
... study was a six-month (24-week), randomized, double-blind, placebo-controlled international trial. It enrolled 669 patients with mid- to late-stage idiopathic Parkinson's disease (more than three years of disease duration) receiving stable doses of levodopa, who had motor fluctuations with >1.5 hours of ...
... CYTOPENIAS, INFUSION REACTIONS, AND INFECTIONS Cytopenias: Serious, including fatal, pancytopenia/marrow hypoplasia, autoimmune idiopathic thrombocytopenia, and autoimmune hemolytic anemia can occur in patients receiving Campath. Single doses of Campath greater than 30mg or cumulative ...
... . Accessed November 12, 2007. 2. Feudjo-Tepie M, Robinson N, Bennett D. Prevalence estimates of adult chronic idiopathic thrombocytopenic purpura (ITP). J Thromb Haemost. 2008; 6(4): 711 - 712. ...
... CYTOPENIAS, INFUSION REACTIONS, AND INFECTIONS Cytopenias: Serious, including fatal, pancytopenia/marrow hypoplasia, autoimmune idiopathic thrombocytopenia, and autoimmune hemolytic anemia can occur in patients receiving Campath. Single doses of Campath greater than 30mg or cumulative ...
... new combination therapy for previously untreated idiopathic thrombocytopenic purpura (ITP), an ... in adult patients with previously untreated idiopathic thrombocytopenic purpura (ITP). The results of ... the Long-Term Treatment of Patients With Chronic idiopathic Thrombocytopenic Purpura (ITP): Results of a ...
... (RA) in adults, and polyarticular juvenile idiopathic arthritis (JIA) in children.(1) ... physical function. Polyarticular juvenile idiopathic arthritis Treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents aged 4 to ...
... at a 24 mcg dose for the treatment of Chronic idiopathic Constipation in adults. These data were among ... About AMITIZA(R) (lubiprostone) for Chronic idiopathic Constipation and IBS-C Indication AMITIZA(R) ... AMITIZA(R) (lubiprostone) in the U.S. for Chronic idiopathic Constipation in adults and Irritable ...
InterMune Announces Progress on Pirfenidone in IPF
... long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF). The roll-over study ... Clinical Trial of Pirfenidone in Patients with idiopathic Pulmonary Fibrosis in Japan" [Session C95], ... at http://www.thoracic.org . About IPF idiopathic pulmonary fibrosis (IPF) is a disabling and ...... to severely active polyarticular juvenile idiopathic arthritis (JIA). ORENCIA may be used as ... such as MTX or TNF antagonists. "Juvenile idiopathic arthritis is the most prevalent form of ... while on open-label treatment. About Juvenile idiopathic Arthritis (JIA) JIA -- also commonly known as ...
... allergies, as well as the treatment of chronic idiopathic urticaria. XYZAL(R) tablets received FDA approval ... runny nose, and itchy eyes. Studies in chronic idiopathic urticaria patients showed levocetirizine ... of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age ...
... Studies in Patients with Moderate-to-Severe idiopathic RLS SP 790 * In a multi-center, double-blind, ... efficacy in patients with moderate-to-severe idiopathic RLS who were treated for 24 months * A total ... States for the treatment of early-stage idiopathic Parkinson's disease and in Europe for the ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. ACTEMRA (known as RoACTEMRA in ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. ACTEMRA (known as RoACTEMRA in ...
... are indicated in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease (PD) and for moderate-to-severe primary restless legs ... and Drug Administration for the treatment of the signs and symptoms of idiopathic Parkinson's disease (PD). Boehringer Ingelheim Pharmaceuticals, Inc. ...
... thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, ... pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The ...
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. The serious adverse ...... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. The serious adverse reactions ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. The serious adverse reactions ...
... research with imatinib mesylate in another non-oncology disease called idiopathic pulmonary fibrosis (IPF), a condition in which the lungs become ... data analysis 6. National Library of Medicine Medical Encyclopedia. idiopathic pulmonary fibrosis. Gleevec(R) (imatinib mesylate) tablets prescribing ...
... tablets) in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease. Requip XL is the first and only oral once-daily ... are indicated in the U.S. for the treatment of the signs and symptoms of idiopathic Parkinson's disease and are administered once daily. Prescription Requip ...
... in April 2008, additional indications for rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis were also approved in Japan. The serious adverse events ...
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
... that its program for the development of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) has received "Fast Track" designation from the ... hepatology. InterMune has a research and development portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The ...... ACTEMRA was approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis and systemic-onset juvenile idiopathic arthritis in Japan. The serious adverse events reported in ACTEMRA ...
FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
... . Accessed November 12, 2007. (2)Cines DB, Blanchette V. idiopathic thrombocytopenic purpura. N Engl J Med. 2002;364: 995-1008. (3)Feudjo-Tepie M, Robinson N, Bennett D. Prevalence estimates of adult chronic idiopathic thrombocytopenic purpura (ITP). J Thromb Haemost. 2008 doi: ...Keppra XR(TM) Extended-Release Tablets Filed with the FDA
... tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. Keppra(R) injection is indicated as adjunctive ... neck pain, and pharyngitis. In patients 6 years of age and older with idiopathic generalized epilepsy, the most common adverse event associated with ...... tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. Keppra(R) injection is indicated as adjunctive ... neck pain, and pharyngitis. In patients 6 years of age and older with idiopathic generalized epilepsy, the most common adverse event associated with ...
... United States for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease, and in Europe for the treatment of patients with ... is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease. Some patients treated with Neupro(R) reported falling ...
... oral gel capsules, twice daily) is indicated for the treatment of Chronic idiopathic Constipation in adults. AMITIZA should not be used in patients with a ... should consult their health professional. In clinical trials for Chronic idiopathic Constipation (24 mcg, oral gel capsules, twice daily), the most common ...
... (abatacept) for the treatment of pediatric patients with juvenile idiopathic arthritis (JIA) who have had an inadequate response to one or more ... signal required for full T-cell activation. About Juvenile idiopathic Arthritis JIA -- also commonly known as juvenile rheumatoid arthritis ...
... support the further development of TELINTRA. Phase 2 studies are ongoing in MDS (enrollment completion expected by year end), and Severe Chronic idiopathic Neutropenia. Reprints of both publications are available from Telik. Background on MDS and TELINTRA MDS is a heterogeneous group of ...
... patients they treat." About the Study The randomized, double-blind, 16-week, placebo-controlled Phase 3 study monitored 405 patients with idiopathic PAH or PAH associated with anorexigen use, connective tissue disease, human immunodeficiency virus (HIV) infection, or congenital ...
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
... indicated to improve exercise ability in WHO Group I PAH patients, which encompasses patients with multiple forms of PAH including etiologies such as idiopathic and familial PAH as well as PAH associated with scleroderma and congenital heart disease. "Today, thanks to the clinical development efforts ...... buffered saline (IA-SA) for level of pain following a 50-Foot Walk Test, measured by 100 mm visual analog scale (VAS). The 586 patients with chronic idiopathic knee OA were randomized to treatment with either product in a 1:1 ratio. Each patient received one weekly injection for 3 weeks with 9 follow-up ...
... This team identified the key role played by this mutation of the JAK2 gene in the development of MPN such as Vaquez disease (Polycythemia Vera), idiopathic Myelofibrose or Essential Thrombocythemia. Following this agreement, the company developed and marketed a complete portfolio of tests for the ...
... hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, psoriasis, lupus, rheumatoid arthritis and interstitial nephritis), pulmonary ...
... the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which a Phase 3 program in ...
Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
... such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF). About the CPF The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts ...... study was a six-month (24-week), randomized, double-blind, placebo-controlled international trial. It enrolled 669 patients with mid- to late-stage idiopathic Parkinson's disease (more than three years of disease duration) receiving stable doses of levodopa, who had motor fluctuations with >1.5 hours of ...
InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
... -- InterMune, Inc. (Nasdaq: ITMN ) today announced that it will report results from its Phase 3 CAPACITY program of pirfenidone in idiopathic pulmonary fibrosis (IPF) prior to market open on Tuesday, February 3. InterMune will conduct a conference call and webcast, with accompanying slide ...InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
... the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is ...... CYTOPENIAS, INFUSION REACTIONS, AND INFECTIONS Cytopenias: Serious, including fatal, pancytopenia/marrow hypoplasia, autoimmune idiopathic thrombocytopenia, and autoimmune hemolytic anemia can occur in patients receiving Campath. Single doses of Campath greater than 30mg or cumulative ...
... . Accessed November 12, 2007. 2. Feudjo-Tepie M, Robinson N, Bennett D. Prevalence estimates of adult chronic idiopathic thrombocytopenic purpura (ITP). J Thromb Haemost. 2008; 6(4): 711 - 712. ...
... CYTOPENIAS, INFUSION REACTIONS, AND INFECTIONS Cytopenias: Serious, including fatal, pancytopenia/marrow hypoplasia, autoimmune idiopathic thrombocytopenia, and autoimmune hemolytic anemia can occur in patients receiving Campath. Single doses of Campath greater than 30mg or cumulative ...
Other ContentsretinalretinalretinalretinalretinalretinolretinopathyretinopathyretinopathypigmentosapigmentosapigmentosaretinitisretinitisretinitisretinoblastomaretinoblastomaretinoblastomaejaculationejaculationretrograderetrograderetrogradeOther TagsVistaWelchMarcoIlluminatedOccluder
(Date:11/25/2009)..., Dr. Sarit Larisch, Head of the Cell Death Res...rtment of Biology, has been awarded the prestigiou...research exploring the cause of brain cell damage ...d each year to scientists in support of innovation... and officially conferred earlier this month at an...
(Date:11/25/2009)..., Over the course of a lifetime, the heart pumps ... In the order to do this, the muscle fibers of the...group headed by Dr. Wolfgang Rottbauer, vice chair...niversity Hospital (Chairman: Prof. Dr. H. A. Katu...or the stability of the smallest muscular unit, th...
(Date:11/25/2009)..., LA JOLLA, CAWhen you eat may be just as vital... at the Salk Institute for Biological Studies. The...ing and waning of thousands of genes in the livert...led by food intake and not by the body,s circadian...ding time determines the activity of a large numbe...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3Young People at High Risk of Death Worldwide 56885 1Young People at High Risk of Death Worldwide 56885 2Vertical farming advocate to be featured at upcoming free lecture at NJIT 9880 1Vertical farming advocate to be featured at upcoming free lecture at NJIT 9880 2Aegis Living Celebrates Assisted Living Week 56880 1Aegis Living Celebrates Assisted Living Week 56880 2Aegis Living Celebrates Assisted Living Week 56880 3(Date:11/27/2009)...ings has announced that it has become a national s...gest nonprofit organizations dedicated to arthriti... Delray Beach, FL (Vocus) November..., a company specializing in the marketing and reta...as announced today that is has become a national s...
(Date:11/27/2009)... bilingual coloring books designed for children ag...nity to educate - inform parents and children alik...inosuars to ABC,S and a host of other topics. , ...ember 27, 2009 -- Today’s children have enou...any hour of the day, but one of the oldest and sim...
(Date:11/26/2009)...mericans living with diabetes will nearly double, ...on in 2034. Over the same period, spending on diab...to $336 billion, even with no increase in the prev...sity of Chicago report in the December issue of D...es covered by Medicare will rise from 8.2 million ...
(Date:11/26/2009)... of the Live Life Again Center, a practice offerin...wing number of physicians who are taking advantag...th individuals who are interested in surgical weig... is utilizing Facebook to share before-and-after p...community. , Dallas, TX (...
(Date:11/25/2009)...e/--TheBartleHallConventionCenterwilltemporarilybe...KansasCityhoststhelatestinaseriesofmassivefreeclin...asthepotentialtobethebiggestoneyet,becauseitwillex...insteadofoveraweekend,"SheriWood,executivedirector...tionalAssociationofFreeClinics(NAFC). ,, Atprev...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2[0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [1] Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books [0] Diabetes cases to double and costs to triple by 2034[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[1] Kansas City Prepares for Largest Free Health Clinic
BANGOLINIAlgerbrushMaltzmanDietzClasenGuimaraesNevyasVistaWelchRefractionMarcoIlluminatedUltramaticOccluder
Other Tagsoils 2oils 3oils 4oils 5fats 2fats 3fats 4fats 5fats 6fats 7fats 8fats 9ring 2ring 3emphysema 2emphysema 3separation 2organ 2organ 3organ 4organ 5organ 6organ 7organ 8organ 9organ 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |